Fulcrum Therapeutics, Inc. (FULC)
3.785
-0.02
(-0.66%)
USD |
NASDAQ |
Sep 24, 16:00
3.785
0.00 (0.00%)
After-Hours: 19:59
Fulcrum Therapeutics Gross Profit (Annual) : -1.39M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -1.39M |
| December 31, 2024 | 78.41M |
| December 31, 2023 | 0.633M |
| December 31, 2022 | 3.928M |
| December 31, 2021 | 16.65M |
| Date | Value |
|---|---|
| December 31, 2020 | 6.444M |
| December 31, 2019 | -2.053M |
| December 31, 2018 | -1.345M |
| December 31, 2017 | -0.715M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Cocrystal Pharma, Inc. | -0.376M |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 257.40M |
| Definium Therapeutics, Inc. | 0.00 |